
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B

The European Commission has granted approval for AstraZeneca’s Imfinzi (durvalumab) combined with FLOT chemotherapy as a perioperative treatment for resectable, early‑stage and locally advanced gastric and gastro‑esophageal junction (G/GEJ) cancers. The decision is based on the Phase III MATTERHORN trial, which enrolled 948 patients and demonstrated a 29% improvement in event‑free survival (EFS) and a 22% reduction in overall mortality risk. At interim analysis, 1‑year EFS rose to 78.2% versus 74% with chemotherapy alone, and three‑year overall survival reached 69% versus 62%. The benefit was consistent regardless of PD‑L1 status, and regulatory review continues in Japan.

GEN Pharmaceuticals received BEBO Foundation ethical approval to launch a Phase II proof‑of‑concept trial of its mitochondrial‑targeting drug SUL‑238 in Parkinson’s disease. The single‑centre, randomised, double‑blind, placebo‑controlled study, named SHEPHERD, will begin patient enrolment in Groningen in April 2026. Over a 28‑day...
Rapid advances in whole‑genome sequencing are prompting frequent revisions to microbial taxonomy and nomenclature, creating operational challenges for clinical microbiology labs. While some updates—such as recognizing Staphylococcus pseudintermedius—enhance antimicrobial‑resistance insight and enable species‑specific susceptibility breakpoints, other changes driven mainly by...
Hypertension affects about 31 % of adults worldwide, and a single office reading often fails to capture true blood‑pressure trends due to stress and white‑coat effects. The American College of Cardiology now recommends home monitoring to supplement annual screenings, providing multiple...
A man with a BRCA1 mutation underwent his first mammogram, discovering that the procedure is virtually identical for men and women. The article highlights the rarity of male breast cancer—about 1 in 726 men—but notes that genetic risk and family...

Maine’s 2026 Senate race has become a bellwether for the Democratic quest to regain a Senate majority, with Governor Janet Mills positioning herself as the party’s most viable challenger to incumbent Susan Collins. Reproductive‑rights groups such as EMILY’s List and...
In a candid essay, infectious‑disease specialist Dr. Mark Crislip recounts his career‑long exposure to death from infections and uses those memories to warn that recent U.S. policy cuts to USAID and vaccination programs could trigger millions of preventable fatalities. He cites...

Tommy Tutone’s iconic phone number 867‑5309 is being rerouted to the Cancer Support Community’s helpline, providing free counseling and resources to patients and caregivers. The campaign, launched in partnership with Gilda’s Club, leverages the cultural cachet of the 1980s hit...
A CAP TODAY roundtable examined how artificial intelligence can streamline urinalysis workflow, particularly through AI‑driven reflex testing that merges urine chemistry and microscopy results with electronic health‑record data. Participants from Sysmex America and Beckman Coulter noted that adoption has been gradual...
Gavi’s 2026 health outlook flags six converging threats—conflict‑driven displacement, climate‑fueled mosquito‑borne disease, a collapse in global health financing, rampant misinformation, the emerging Marburg virus, and the looming “Disease X.” The United States’ 2025 aid freeze left Kenya without 41,500 community health...
A coalition of 128 Democratic lawmakers has urged the Health and Human Services Department to grant a one‑year extension for Title X funding as the program faces a March 31 deadline. HHS missed its Dec 31 guidance deadline, opening grant applications with only...

The article highlights a systemic gap in U.S. organ donation where a donor’s later “no” can be overridden by an earlier “yes” from another state, as illustrated by the case of Raven Kinser. State‑based donor registries and the private, federally...

The White House is intensifying pressure on Congress to pass a “most‑favored nation” drug‑pricing bill that would cap U.S. medication prices at levels paid by peer nations. Administration officials say the proposal would overhaul pricing for providers, insurers, federal programs...

Clinical trials are adopting integrated eCOA platforms that connect medical devices directly to digital systems, eliminating manual data entry and improving data quality. Interoperability enables real‑time monitoring and AI‑driven insights, reducing patient burden especially in long‑duration obesity studies. The obesity...
Temporal interference (TI) stimulation uses two high‑frequency electrical currents that intersect to generate a low‑frequency envelope capable of modulating deep‑brain activity without surgery. Early human pilots have reported seizure suppression and better sleep in epilepsy, improved motor learning after stroke,...

Attacks on hospitals have surged worldwide, with the WHO confirming 27 strikes in Lebanon alone and MSF reporting 1,348 incidents in 2025, double the previous year. High‑profile cases include a Pakistani airstrike on a Kabul drug‑rehab centre and an Israeli...

The One Big Beautiful Bill Act (OBBBA) introduces sweeping reforms that will reshape how Americans access and pay for health care through 2028. New mandates, such as semi‑annual Medicaid eligibility checks, force providers to adopt automation and AI to maintain...

The Medicare Payment Advisory Commission (MedPAC) has recommended a 7% reduction in the Medicare fee‑for‑service home health payment rate for 2027, projecting $750 million in savings in the first year and up to five‑year cumulative cuts. The National Alliance for Care...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is steering a push to expand the National Vaccine Injury Compensation Program (VICP) to cover autism spectrum disorder claims. Recent actions include a proposal to amend the VICP Injury Table,...
Dilated cardiomyopathy (DCM) weakens and thins the left‑ventricular wall, causing the heart to enlarge, while hypertrophic cardiomyopathy (HCM) thickens that wall and can obstruct blood flow. Both conditions present with similar symptoms—shortness of breath, fatigue, chest pain—but their underlying mechanisms...
Early‑stage breast cancer patients face a lingering concern about recurrence, which can be local, regional, or distant. Dr. Margaret Thompson explains that recurrence rates have fallen over the past two decades thanks to improved surgery, radiation, and systemic therapies. Individual...
Respiratory syncytial virus (RSV) commonly presents as a cold in infants, but babies under six months can develop bronchiolitis that quickly impairs breathing. Pediatrician Dr. Kristin Barrett advises parents to monitor peak symptom days (days 3‑5) and watch for red‑flag...

Leucovorin prescriptions for autistic children jumped 71% after a White House briefing promoted the drug, yet the FDA only approved it for cerebral folate deficiency and withdrew any autism claim. A 2024 autism trial supporting leucovorin was retracted, casting doubt...
Women spend an estimated $4,700 more per year in out-of-pocket healthcare costs than men, for conditions that often go undiagnosed for a decade. Who built this system and who did they build it for?

Australia released its first 24‑hour movement guidelines for adults, adding sleep recommendations and step targets. The guidance emphasizes 7‑9 hours of quality sleep and 7,000 daily steps but stops at advice without funding or regulatory changes. Critics argue that without...
San Juan Regional Medical Center, a rural hospital serving the Four Corners region, has implemented Wellsheet, a clinical AI platform that embeds UpToDate evidence directly into the electronic health record. The adoption, launched in January 2026, is driven by chronic...
The International Osteoporosis Foundation has launched Build Better Bones, a multilingual, user‑centered website that supports self‑management for people with osteoporosis and their caregivers. Developed through design‑thinking and agile methods, the platform offers evidence‑based guidance on exercise, nutrition, home safety, and...
NeuroScientific Biopharmaceuticals has begun its first manufacturing run of the StemSmart mesenchymal stem cell therapy at Q‑Gen Cell Therapeutics in Brisbane, initiating a critical technology transfer. The engineering run will validate quality, potency and regulatory compliance ahead of a Phase 2...

An estimated 30 million Americans have obstructive sleep apnea. GLP-1 medications are producing weight loss at a scale we haven’t seen before. A 20% loss makes apnea 53% less severe. Something that doesn’t get enough attention: sleep is a metabolic intervention....
Where's the obituary for the millions of poor Indians who were forcibly sterilized by international programs directly inspires by Ehrlich's work? Or would that story be "premature"?
Abeona Therapeutics reported its Q4 2018 results, highlighting progress on its lead cell therapy EB-101 for recessive dystrophic epidermolysis bullosa (RDEB). The Phase 1/2 trial demonstrated continuous type VII collagen expression for over two years, a favorable safety profile, and durable wound...

Why do women account for nearly 2/3rd of all cases of Alzheimer's disease? A new, thorough review @jclinicalinvest, open-access, on its origins in midlife. https://t.co/obITwhEiYG https://t.co/RXBffM9jKV
HealthEquity posted a strong Q1 FY2026, with revenue climbing 15% year‑over‑year to roughly $1.1 billion and adjusted EBITDA rising 19% to $140.2 million, pushing the EBITDA margin to 42%. HSA assets surged 15% to $31 billion, driven by a 16% jump in investing...
Pacific Health Care Organization (PFHO) reported record Q4 2025 results, with health‑plan membership rising 25% to 236,300 and total revenue climbing 46% to $3.9 billion. Adjusted EBITDA surged from $1 million in 2024 to $110 million, delivering a 2.8% margin and an MBR...
Geron reported full‑year 2025 net revenue of $184 million from Rytelo, with Q4 sales of $48 million, and projected 2026 revenue of $220‑240 million. Operating expenses are expected to fall to $230‑240 million, reflecting lower R&D spend and modest SGA reductions after a restructuring....

The Office of the Assistant Secretary for Technology Policy and the ONC launched nine pilot programs across nine jurisdictions, involving 45 organizations, to test behavioral health data‑exchange standards using the USCDI+ dataset and FHIR profiles, backed by roughly $20 million from...

The FDA released draft guidance on flavored electronic nicotine delivery systems (ENDS) that seeks to clarify evidentiary expectations for pre‑market tobacco product applications. The article argues the guidance should better reflect Section 910 of the Tobacco Control Act, which requires an...

Chronologix unveiled a safety-first AI architecture designed for mental health and chronic care coaching. The platform embeds multi‑layered guardrails that monitor user behavior, detect distress signals, and trigger escalation to professional resources. It deliberately avoids providing medical diagnoses, focusing instead...
A systematic review published in Lancet Psychiatry, analysing 54 randomized controlled trials from 1980‑2025, found no evidence that medicinal cannabis treats depression, anxiety or PTSD. The paper highlights modest benefits for conditions such as epilepsy, multiple sclerosis spasticity, pain and...

A federal district court in Massachusetts issued a preliminary injunction that temporarily bars the Department of Health and Human Services from convening Advisory Committee on Immunization Practices (ACIP) meetings with its current members and from implementing changes to the CDC...

Congressional committees are convening a series of hearings in mid‑March to address rising health‑care costs, targeting insurer practices, hospital pricing, and pharmaceutical supply chains. The Energy and Commerce Subcommittee on Health will examine site‑neutral payment models, while the Oversight &...

A University of Queensland review of 230 international studies found telehealth consultations clinically effective and operationally robust, even for sensitive care such as voluntary assisted dying (VAD). Australian federal law still classifies certain remote counselling as unlawful, creating legal uncertainty...

Roche announced a new AI factory, adding 2,176 Nvidia Blackwell GPUs to its existing pool and bringing total GPU count above 3,500 – the highest in the pharmaceutical sector. The purchase, likely costing $65 million or more, aims to accelerate drug...

The FDA has shed roughly 20% of its workforce after the DOGE cuts, prompting a rapid rollout of artificial intelligence tools to offset the expertise gap. Among its centers, CDER is beginning to stabilize, CDRH remains relatively insulated, while CBER...

A UCLA Health study links long‑term residential exposure to the pesticide chlorpyrifos with a more than 2.5‑fold increase in Parkinson's disease risk. Researchers analyzed 829 Parkinson's patients and 824 controls, estimating exposure through California pesticide records, and corroborated findings with...
i got an elective mammogram earlier this year (im 31). they found something concerning before we knew what it was: "thank god you came in early" after we (thankfully) found out it was benign, same doctor: "you really shouldn't be getting...

Lung cancer remains the world’s deadliest cancer, accounting for 1.8 million deaths in 2020. Early detection dramatically improves outcomes—five‑year survival jumps from under 30 % overall to about 60 % when diagnosed early, and low‑dose CT screening can push 20‑year survival above 80 %....
The TrumpRx website now lists 54 prescription drugs after adding seven products from GlaxoSmithKline and Amgen. The expansion pushes the total from 47 to 54, but health‑policy analysts note that the majority are older medicines nearing the end of their...
Mission Hospital in Asheville received its third immediate jeopardy designation from CMS within two years, prompting the submission of an enhanced plan of correction. The plan, accepted by CMS on February 2, 2026, calls for a root‑cause analysis, a review...

On July 23, 2020 the FDA issued new recommendations urging health‑care professionals to discuss and consider prescribing naloxone for any patient at heightened risk of opioid overdose. The guidance covers three groups: patients on opioid pain relievers, patients receiving medications...